Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PROSTASCINT DIN 02329735

Status: Cancelled Pre Market
Holder: EUSA PHARMA INC
Molecule: CAPROMAB PENDETIDE

Health Canada record

Active ingredient(s)CAPROMAB PENDETIDE 0.5 MG
Dosage formLiquid
RouteIntravenous
ScheduleSCHEDULE C
ClassRadiopharmaceutical
ATC
Original market date
Current status date07-Sep-2022
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Request a quote for PROSTASCINT

How to read a Canadian DIN record